1. Home
  2. RNAZ vs DUO Comparison

RNAZ vs DUO Comparison

Compare RNAZ & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAZ
  • DUO
  • Stock Information
  • Founded
  • RNAZ 2016
  • DUO 2011
  • Country
  • RNAZ United States
  • DUO China
  • Employees
  • RNAZ N/A
  • DUO N/A
  • Industry
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • DUO Real Estate
  • Sector
  • RNAZ Health Care
  • DUO Finance
  • Exchange
  • RNAZ Nasdaq
  • DUO Nasdaq
  • Market Cap
  • RNAZ 6.1M
  • DUO 6.1M
  • IPO Year
  • RNAZ 2021
  • DUO 2019
  • Fundamental
  • Price
  • RNAZ $11.36
  • DUO $3.24
  • Analyst Decision
  • RNAZ Strong Buy
  • DUO
  • Analyst Count
  • RNAZ 1
  • DUO 0
  • Target Price
  • RNAZ $280.00
  • DUO N/A
  • AVG Volume (30 Days)
  • RNAZ 10.7K
  • DUO 6.2M
  • Earning Date
  • RNAZ 11-13-2025
  • DUO 08-29-2025
  • Dividend Yield
  • RNAZ N/A
  • DUO N/A
  • EPS Growth
  • RNAZ N/A
  • DUO N/A
  • EPS
  • RNAZ N/A
  • DUO N/A
  • Revenue
  • RNAZ N/A
  • DUO $56,189,313.00
  • Revenue This Year
  • RNAZ N/A
  • DUO N/A
  • Revenue Next Year
  • RNAZ N/A
  • DUO N/A
  • P/E Ratio
  • RNAZ N/A
  • DUO N/A
  • Revenue Growth
  • RNAZ N/A
  • DUO 48.30
  • 52 Week Low
  • RNAZ $6.15
  • DUO $1.24
  • 52 Week High
  • RNAZ $739.20
  • DUO $74.72
  • Technical
  • Relative Strength Index (RSI)
  • RNAZ 56.35
  • DUO 56.68
  • Support Level
  • RNAZ $10.67
  • DUO $3.00
  • Resistance Level
  • RNAZ $11.45
  • DUO $3.59
  • Average True Range (ATR)
  • RNAZ 0.61
  • DUO 0.81
  • MACD
  • RNAZ 0.10
  • DUO 0.04
  • Stochastic Oscillator
  • RNAZ 83.81
  • DUO 45.60

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: